Exicure, Inc.
XCUR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001698530
No open-market purchases or sales by Exicure, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $306.0K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Exicure, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Exicure, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| HiTron Systems Inc. | 10% Owner | 2,222,224 | Jul 17, 2026 | 4 |
| Miller Josh | Chief Accounting Officer | 301 | Feb 19, 2026 | 2 |
| Sangsangin Investment & Securities Co., Ltd. | 10% Owner | 0 | Dec 10, 2025 | 1 |
| DGP Co., Ltd. | 10% Owner | 849,223 | Sep 16, 2024 | 0 |
| CBI USA, Inc. | 10% Owner | 818,299 | Jun 27, 2023 | 0 |
| Hwang Jiyoung | Director | – | Jan 4, 2023 | 0 |
| Sulat James R | Director | – | Jun 15, 2022 | 0 |
| Cleland Jeffrey L | Director | – | Jun 15, 2022 | 0 |
| Muralidhar Bali | Director | 8,449,126Indirect | Jun 15, 2022 | 0 |
| Garofalo Elizabeth A. | Director | – | Jun 15, 2022 | 0 |
| Longoria Sarah | Chief HR & Compliance Officer | – | May 20, 2022 | 0 |
| Schroff Matthias | Chief Executive Officer | – | May 18, 2022 | 0 |
| Papadimas Elias D. | Chief Financial Officer | 10,000Indirect | May 18, 2022 | 0 |
| Gates William H III | 10% Owner | 5,064,703 | Dec 22, 2021 | 0 |
| Gates Frontier, LLC | 10% Owner | 5,064,703 | Dec 22, 2021 | 0 |
| Giljohann David A | Chief Executive Officer | 38,666 | Nov 23, 2021 | 0 |
| Feltner Douglas E. | Chief Medical Officer | 15,000 | Nov 23, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 21, 2026 (view filing) | Jan 21 | Same day | HiTron Systems Inc.10% Owner | SSale | −258.4K | $4.50 | −$1.16M | −13.9%1.60M after | |
| Jan 20, 2026 (view filing) | Jan 16 | 4 days | HiTron Systems Inc.10% Owner | SSaleCommon | −734.7K | $4.50 | −$3.31M | −28.3%1.86M after | |
| Jan 8, 2026 (view filing) | Jan 7 | 1 day | HiTron Systems Inc.10% Owner | SSaleCommon | −741.3K | $4.50 | −$3.34M | −22.2%2.59M after | |
| Dec 10, 2025 (view filing) | Dec 8 | 2 days | Sangsangin Investment & Securities Co., Ltd.10% Owner | SSale | −433.3K | $8.71 | −$3.77M | −100.0%0 after | |
| Mar 26, 2025 (view filing) | Dec 26, 2024 | 90 daysLate | HiTron Systems Inc.10% Owner | PPurchase | +2.90M | $3.00 | +$8.70M | +669.2%3.33M after | |
| Sep 16, 2024 (view filing) | Sep 12 | 4 days | DGP Co., Ltd.10% Owner | PPurchase | +237.2K | $3.00 | +$711.7K | +38.8%849.2K after | |
| Mar 4, 2024 (view filing) | Feb 29 | 4 days | DGP Co., Ltd.10% Owner | SSale | −3.40M | $1.32 | −$4.49M | −100.0%0 after | |
| Dec 19, 2022 (view filing) | Dec 15 | 4 days | CBI USA, Inc.10% Owner | PPurchase | +3.40M | $1.60 | +$5.44M | +415.5%4.22M after | |
| May 19, 2022 (view filing)4:50 PM ET | May 19 | Same day | Muralidhar BaliDirector | PPurchase | +1.47M | $0.1937 | +$285.2K | +21.1%8.45M after | |
| Dec 22, 2021 (view filing)4:13 PM ET | Dec 21 | 1 day | Gates William H III and 1 other10% Owner | SSale | −1.27M | $0.239 | −$303.2K | −20.0%5.06M after | |
| Sep 8, 2021 (view filing) | Aug 27 | 12 daysLate | Papadimas Elias D.Chief Accounting Officer | PPurchase | +10.0K | $1.38 | +$13.8K | New position10.0K after |